the value of real-world data in myeloma treatment
Published 2 years ago • 39 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
2:25
the importance of real-world data in multiple myeloma
-
1:54
using real-world data to optimize treatment in patients with multiple myeloma
-
2:45
myeloma: real-world data
-
3:52
real-world data on outcomes of t(11;14) multiple myeloma
-
3:56
real-world analysis of treatment patterns and outcomes in newly diagnosed myeloma
-
21:38
drawing the line: the rationale behind blood tube collection order
-
55:08
real-world car-t data update
-
6:56
how is active myeloma defined?
-
1:33
teclistamab for multiple myeloma in us hospitals: real-world data analysis
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
1:37
long-term follow-up from a phase ii trial of olutasidenib in idh1-mutated aml
-
4:23
proteasome inhibitors in myeloma treatment
-
1:30
real-world insight for myeloma
-
2:00
real-world outcomes of autosct for multiple myeloma in the first-line setting
-
2:53
real-world data on upfront subcutaneous bortezomib-containing regimens for newly diagnosed myeloma
-
1:27
the real world utilization of mrd in myeloma across europe
-
1:53
the future of multiple myeloma treatment
-
0:32
the importance of obtaining real-world data
-
0:59
defining the origins of multiple myeloma
-
3:41
emerging therapies for r/r myeloma
-
1:21
what is the pcrowd study, and how does knowledge in myeloma biology help with new treatments?
-
4:12
insight-mm: real-world analysis of dot with rd-based regimens in r/r myeloma